Oberland Capital Management LLC

About The Fund

Oberland Capital Management LLC is a private investment firm focused on the healthcare industry, aiming to accelerate the development and commercialization of healthcare products. Their purpose is to create value for their partners and transform patient care. With approximately $3.2 billion in assets under management, they specialize in a variety of flexible investment structures tailored to meet the specific needs of their partners. These structures include the monetization of royalty streams, acquisition of future product revenues, and the creation of project-based financing structures, alongside investments in traditional debt and equity. Since its founding in 2013, Oberland Capital has pursued a strategy that stands out due to its flexible structures, global reach, deep domain expertise, and the ability to provide meaningful scale of capital ranging from $50 million to $300+ million. Their investment approach is designed to accommodate the specific strategic and financial objectives of management teams, adapting innovative financing to local legal, tax, and accounting frameworks globally. With a deep understanding of the life sciences sector, Oberland Capital's team deploys its scientific, operational, and financial knowledge to address the complexities of product development and commercialization. They engage in a variety of specialized investment activities including MBO/LBO, special situations, distressed debt, and their investment size ranges from a minimum of $20 million to a maximum of $100 million. The firm's headquarters are at 1700 Broadway, 37th Floor, New York, New York, 10019, United States, exemplifying their centralized approach to managing extensive assets.